相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma
Xiaohu Huang et al.
CANCERS (2021)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
Yin Wang et al.
ONCOGENE (2020)
Single-cell RNA sequencing identifies novel cell types in Drosophila blood
Yulong Fu et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
RAS mutations in acute myeloid leukaemia patients: A review and meta-analysis
Xin Liu et al.
CLINICA CHIMICA ACTA (2019)
The role of hypoxia-inducible factors in leukemias
Donata Szymczak et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
Adam J. Lamble et al.
FRONTIERS IN ONCOLOGY (2018)
Thioester-Containing Protein-4 Regulates the Drosophila Immune Signaling and Function against the Pathogen Photorhabdus
Upasana Shokal et al.
JOURNAL OF INNATE IMMUNITY (2017)
PP6 Disruption Synergizes with Oncogenic Ras to Promote JNK-Dependent Tumor Growth and Invasion
Xianjue Ma et al.
CELL REPORTS (2017)
The Immune Phenotype of Three Drosophila Leukemia Models
Badrul Arefin et al.
G3-GENES GENOMES GENETICS (2017)
Epidermal Growth Factor Pathway Signaling in Drosophila Embryogenesis: Tools for Understanding Cancer
Jay B. Lusk et al.
CANCERS (2017)
Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer
Michelle S. Bousquet et al.
ACS CHEMICAL BIOLOGY (2016)
Multimodal imaging of a humanized orthotopic model of hepatocellular carcinoma in immunodeficient mice
Tao Wu et al.
SCIENTIFIC REPORTS (2016)
Hypoxia and Hypoxia-inducible Factors in Leukemias
Margaux Deynoux et al.
FRONTIERS IN ONCOLOGY (2016)
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
Julian Downward
CLINICAL CANCER RESEARCH (2015)
Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells
Yin Wang et al.
BLOOD (2014)
Transcriptional regulation by hypoxia inducible factors
Veronica L. Dengler et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Oncogenic Ras stimulates Eiger/TNF exocytosis to promote growth
Chiswili Chabu et al.
DEVELOPMENT (2014)
Drosophila hematopoiesis: Markers and methods for molecular genetic analysis
Cory J. Evans et al.
METHODS (2014)
Systematic screen of chemotherapeutics in Drosophila stem cell tumors
Michele Markstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Ryan B. Corcoran et al.
CANCER CELL (2013)
Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer
Hyun Seok Kim et al.
CELL (2013)
An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery
Lee F. Willoughby et al.
DISEASE MODELS & MECHANISMS (2013)
Direct reprogramming by oncogenic Ras and Myc
Irene Ischenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Anurag Singh et al.
CELL (2012)
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
Michael Steckel et al.
CELL RESEARCH (2012)
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
Arvin C. Dar et al.
NATURE (2012)
STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells
Carol Babij et al.
CANCER RESEARCH (2011)
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang et al.
CELL STEM CELL (2011)
Cancer Therapeutic Agents Targeting Hypoxia-Inducible Factor-1
R. Wang et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Chemical genetics and drug screening in Drosophila cancer models
Mara Gladstone et al.
JOURNAL OF GENETICS AND GENOMICS (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models
Silvestre Vicent et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes
Sang Y. Chun et al.
MOLECULAR CANCER (2010)
Interaction between RasV12 and scribbled clones induces tumour growth and invasion
Ming Wu et al.
NATURE (2010)
Lineage Tracing of Lamellocytes Demonstrates Drosophila Macrophage Plasticity
Martin Stofanko et al.
PLOS ONE (2010)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl et al.
CELL (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
Dual Role of Wingless Signaling in Stem-like Hematopoietic Precursor Maintenance in Drosophila
Sergey A. Sinenko et al.
DEVELOPMENTAL CELL (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Targeting Ras in myeloid leukemias
Benjamin S. Braun et al.
CLINICAL CANCER RESEARCH (2008)
Innate immunity in Drosophila:: Pathogens and pathways
Shubha Govind
INSECT SCIENCE (2008)
Drosophila-based in vivo assay for the validation of inhibitors of the epidermal growth factor receptor/Ras pathway
Anuradha Aritakula et al.
JOURNAL OF BIOSCIENCES (2008)
Drosophila hemopoiesis and cellular immunity
Michael J. Williams
JOURNAL OF IMMUNOLOGY (2007)
Nimrod, a putative phagocytosis receptor with EGF repeats in Drosophila plasmatocytes
Eva Kurucz et al.
CURRENT BIOLOGY (2007)
Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells
Aparna V. Sarthy et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Drosophila models for cancer research
M Vidal et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Using Drosophila melanogaster to map human cancer pathways
AM Brumby et al.
NATURE REVIEWS CANCER (2005)
A genetic screen in Drosophila for metastatic behavior
RA Pagliarini et al.
SCIENCE (2003)
scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila
AM Brumby et al.
EMBO JOURNAL (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
